Why is "Liver cancer" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-04-05 11:00:49
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Liver cancer, also known as hepatic cancer, primary hepatic cancer, or primary hepatic malignancy, is cancer that starts in the liver. Liver cancer can be primary in which the cancer starts in the liver, or it can be liver metastasis, or secondary, in which the cancer spreads from elsewhere in the body to the liver. Liver metastasis is the more common of the two liver cancers. Instances of liver cancer are increasing globally.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Mount Sinai Performs First-in-the-World Liver Cancer Treatment Using More Flexible Scheduling Approach - Mount Sinai
-
Does solar jet lag contribute to liver cancer? - Fred Hutchinson Cancer Center
-
EMERALD-3 Trial Shows Imfinzi-Based Combination Delays Liver Cancer Progression - Cure Today
-
Another AstraZeneca Emerald glimmers as Imfinzi, Imjudo delay liver cancer progression - Fierce Pharma
-
AstraZeneca touts quadruplet approach in earlier-stage liver cancer - FirstWord Pharma
-
AstraZeneca's liver cancer therapy combo slows disease progression in late-stage trial - Reuters
-
AI tool could help clinicians detect liver cancer risk earlier - Medical News Today
-
AZ claims another win for Imfinzi in frontline liver cancer - pharmaphorum
-
Imfinzi plus Imjudo combined with lenvatinib and TACE demonstrated a statistically significant and clinically meaningful improvement in progression-free survival in embolisation-eligible unresectable liver cancer in EMERALD-3 Phase III trial - AstraZeneca
-
Imfinzi and Imjudo combo improves outcomes in earlier stage liver cancer - The Pharma Letter
-
AstraZeneca's liver cancer therapy combo slows disease progression in late-stage trial - Yahoo
-
Lipocine’s postpartum depression drug fails; AstraZeneca claims liver cancer win - Endpoints News
-
Y90-radioembolization radiation therapy for liver cancer patients - UT MD Anderson
-
Discover Answers to Liver Cancer: Free HCC Lunch & Learn Empowers Houston Community - 24-7 Press Release Newswire
-
IMFINZI® (durvalumab) + IMJUDO® (tremelimumab-actl) improves PFS in early liver cancer - Business Wire
-
Can a Machine Learning Model Predict Liver Cancer? - Medscape
-
Washington Post. . Crew Dearth, 2, is a liver cancer survivor whose “life was changed by a living donor,” according to the Cleveland Clinic. Crew walked down the hospital’s hallways to ring the Bravery Bell to celebrate the end of his cancer treatment. - facebook.com
-
Regular dental care linked to fewer complications, lower liver cancer risk in veterans with cirrhosis - VCU Health
-
Astra posts trial win for Imfinzi combo in liver cancer (AZN) - Seeking Alpha
-
Study reveals how a rare pediatric liver cancer emerges and its response to therapy - Baylor College of Medicine Blog Network -
-
AstraZeneca’s liver cancer therapy combo slows disease progression in late-stage trial - WKZO
-
AstraZeneca Reports Strong Liver Cancer Results for Imfinzi–Imjudo Combo in EMERALD-3 Trial - TipRanks
-
How a Simple Dietary Change May Slow Liver Cancer in At-Risk Patients - Rutgers University
-
Surgery After Immunotherapy Boosts Survival for Liver Cancer Patients - Cedars-Sinai
-
IMFINZI® and IMJUDO® Combo Improves Liver Cancer Outcomes - National Today
-
American Liver Foundation Hosted Liver Cancer Briefing on Capitol Hill - American Liver Foundation
-
Drug lifts barrier for immunotherapy to fight rare liver cancer - Cornell Chronicle
-
AstraZeneca's liver cancer therapy combo slows disease progression in late-stage trial - MarketScreener
-
Hepatitis C and liver cancer: What to know - UT MD Anderson
-
AstraZeneca Says Liver Cancer Drug Combination Extends Progression-Free Survival in Phase 3 Trial - MarketScreener
-
AstraZeneca (NYSE: AZN) liver cancer combo boosts PFS in Phase III - Stock Titan
-
How to lower your risk of liver cancer - UChicago Medicine
-
AstraZeneca's liver cancer therapy combo slows disease progression in late-stage trial - TradingView
-
David Bowie’s Secret Battle with Liver Cancer: The Story Behind His Final Masterpiece - Oncodaily
-
Chronic stress drives liver cancer by impairing the hepatic kynurenine pathway and immune surveillance - Nature
-
MIT study shows high-fat diets give liver cancer a dangerous head start - ScienceDaily
-
AstraZeneca’s Liver Cancer Treatment Shows Promise in Phase III Trial - AskTraders.com
-
A double-edged sword: Chronic cellular stress promotes liver cancer—but also makes tumors vulnerable to immunotherapy - Medical Xpress
-
Dr. Su Wang on the Hepatitis B Birth Dose and Liver Cancer - HepVu
-
Novel Liver Cancer Vaccine Achieves Responses in Rare Disease Affecting Children and Young Adults - Johns Hopkins Medicine
-
Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer - Nature
-
Five Things You May Not Know About Liver Cancer—from Managing Risks to Treating Disease - nyulangone.org
-
Ablation Success Rate for Liver Cancer. What Patients Need to Know in 2026 - Oncodaily
-
AstraZeneca upbeat on results of liver cancer treatment trial - Sharecast.com
-
As liver cancer rates surge, advances in treatment bring hope - Johns Hopkins University
-
SNORA49 negatively regulates self-renewal of liver cancer stem cells and hepatocarcinogenesis via suppressing SOX9 transcription - Nature
-
Research on liver cancer pathology image recognition based on deep learning image processing | Scientific Reports - Nature
-
Liver Cancer Success Rate: What Patients Need to Know in 2025 - Oncodaily
-
Liver Cancer Trends and AI Advances in Heart, Brain Science - Cedars-Sinai
-
Dual Immunotherapy with Durvalumab and Tremelimumab Improves Progression-Free Survival in Early-Stage Liver Cancer - geneonline.com
-
ACLY inhibition promotes tumour immunity and suppresses liver cancer - Nature
-
Liver Cancer in US Military Veterans [2026 Update] - robertkinglawfirm.com
-
Liver cancer: More cases, but better treatment - newsroom.osfhealthcare.org
-
How artificial intelligence (AI) technology is helping doctors understand liver cancer - Hepatitis B Foundation
-
UTSW named Specialized Program of Research Excellence for liver cancer - utsouthwestern.edu
-
Reversing the rise of liver cancer - The Lancet
-
Liver disease and liver cancer are on the rise. Are they preventable? - UCHealth
-
MSU Lab’s AI ‘GPS’ Zeroes In On Drug Hope For Deadly Liver Cancer, Lung Scarring - Hoodline
-
Blood Test May Offer Early Warning of Liver Cancer Recurrence After Liver Transplant - cancerhealth.com
-
Efficacy and safety of AiDi injection in treating primary liver cancer: a systematic review on 70 randomized controlled trials - Nature
-
Using nature to fight liver cancer | UDaily - University of Delaware
-
MU Health Care, MURR begin next steps for new liver cancer treatment - columbiamissourian.com
-
AstraZeneca reports positive phase III results for Imfinzi and Imjudo in liver cancer - Investing.com Australia
-
Biomarkers indicating higher liver cancer risk in chronic hepatitis B patients identified - Medical Xpress
-
Common Heart Medication Shows Promise Against Liver Cancer - University of Mississippi | Ole Miss
-
The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active - Nature
-
Trends and Disparities in Liver Cancer Incidence by Demographic Factors in the United States (1999-2020) - Cureus
-
Gut bacterium may sabotage liver cancer immunotherapy, study suggests - Medical Xpress
-
Rare infant triplet overcomes one-in-a-million type of liver cancer - michiganmedicine.org
-
Interrogating subclonal heterogeneity of liver cancer with single-cell multi-omics analysis - Nature
-
Coordinated cancer care at Ascension Wisconsin brings hope after liver cancer diagnosis - Healthcare | Ascension
-
Three in Five Liver Cancer Cases May Be Due to Preventable Risk Factors, The Lancet Commission Finds - The ASCO Post
-
3 Out of 5 Liver Cancer Cases Are Preventable, Study Finds - The New York Times
-
Liver cancer prevention, treatment efforts are working - Medical Xpress
-
Activated Gene Promotes Liver Cancer but Also Improves Immunotherapy Response - Genetic Engineering and Biotechnology News
-
Single-Breath 3D MRI Revolutionizes Liver Cancer Diagnosis - Bioengineer.org
-
Machine-learned biomarker identifies those at high risk for liver cancer - riken.jp
-
Collaboration Means Better Outcomes for Patients With Liver Cancer - Lehigh Valley Health Network
-
BCLC 2025 Guidelines introduce a new model to personalize liver cancer treatment - Hospital Clínic Barcelona
-
Surgery After Immunotherapy Boosts Survival for Liver Cancer Patients - cancerhealth.com
-
Multi-omic assessment of mRNA translation dynamics in liver cancer cell lines - Nature
-
‘We never stopped believing’: Benny’s journey with liver cancer - answers.childrenshospital.org
-
UCSF Offers Histotripsy: Non-Invasive, No-Radiation Liver Cancer Treatment - UCSF Radiology
-
Rate of new liver cancer diagnoses in the U.S. as of 2022, by age - statista.com
-
Novant Health Cancer Institute introduces next-generation treatment for liver cancer - Novant Health
-
NYU Langone Perlmutter Cancer Center Names Renowned Liver Cancer Researcher to Lead Its Liver Cancer Program - nyulangone.org
-
Hepatitis B virus promotes liver cancer by modulating the immune response to environmental carcinogens - Nature
-
Use precontrast, low attenuation CT to better identify liver cancer - auntminnie.com
-
Liver cancer cases are projected to double, but more than half could be preventable - NBC News
-
Study reveals targeted therapy for aggressive liver cancer - Medical Xpress
-
Saint Francis offering ‘tumor-liquefying robot’ to some liver cancer patients - News On 6
-
‘Conservative’ estimate: More than 60% of liver cancer cases could be prevented - Healio
-
PANoptosis emerges as a promising strategy against liver cancer - News-Medical
-
Study Identifies Ways to Lower Risk of Liver Cancer for People with Hepatitis B Infection - Mass General Brigham
-
Karmanos Shines a Green Light on Liver Cancer in October: Know the Risks, Know the Signs - PR Newswire
-
Don’t wait for symptoms – get checked for hepatitis, say liver cancer patient and experts in Viet Nam ahead of World Hepatitis Day - World Health Organization (WHO)
-
Rising liver cancer rates highlight need for urgent action worldwide - News-Medical
-
The CRP–albumin–lymphocyte index provides enhanced prognostic value in liver cancer compared to the TNM staging system - Nature
-
Targeting the p38/MAPK pathway to induce apoptosis: a multidimensional mechanistic exploration of Mentha and its active compound diosmetin against liver cancer - Nature
-
Liver cancer cases could double by 2050, but 60% are preventable - Euronews.com
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.